245 related articles for article (PubMed ID: 38376950)
1. Impaired T3 uptake and action in MCT8-deficient cerebral organoids underlie Allan-Herndon-Dudley syndrome.
Salas-Lucia F; Escamilla S; Bianco AC; Dumitrescu A; Refetoff S
JCI Insight; 2024 Feb; 9(7):. PubMed ID: 38376950
[TBL] [Abstract][Full Text] [Related]
2. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
Morte B; Gil-Ibañez P; Heuer H; Bernal J
Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
[No Abstract] [Full Text] [Related]
3. AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-Deficiency.
Liao XH; Avalos P; Shelest O; Ofan R; Shilo M; Bresee C; Likhite S; Vit JP; Heuer H; Kaspar B; Meyer K; Dumitrescu AM; Refetoff S; Svendsen CN; Vatine GD
Thyroid; 2022 Jul; 32(7):849-859. PubMed ID: 35350867
[No Abstract] [Full Text] [Related]
4. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
Armour CM; Kersseboom S; Yoon G; Visser TJ
PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
[TBL] [Abstract][Full Text] [Related]
6. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
[TBL] [Abstract][Full Text] [Related]
7. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.
Mayerl S; Müller J; Bauer R; Richert S; Kassmann CM; Darras VM; Buder K; Boelen A; Visser TJ; Heuer H
J Clin Invest; 2014 May; 124(5):1987-99. PubMed ID: 24691440
[TBL] [Abstract][Full Text] [Related]
8. Disorder of thyroid hormone transport into the tissues.
Groeneweg S; Visser WE; Visser TJ
Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):241-253. PubMed ID: 28648511
[TBL] [Abstract][Full Text] [Related]
9. From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development.
Vancamp P; Darras VM
Gen Comp Endocrinol; 2018 Sep; 265():219-229. PubMed ID: 29183795
[TBL] [Abstract][Full Text] [Related]
10. In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
Kersseboom S; Horn S; Visser WE; Chen J; Friesema EC; Vaurs-Barrière C; Peeters RP; Heuer H; Visser TJ
Mol Endocrinol; 2014 Dec; 28(12):1961-70. PubMed ID: 25389909
[TBL] [Abstract][Full Text] [Related]
11. TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice.
Reinwald JR; Weber-Fahr W; Cosa-Linan A; Becker R; Sack M; Falfan-Melgoza C; Gass N; Braun U; Clemm von Hohenberg C; Chen J; Mayerl S; Muente TF; Heuer H; Sartorius A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555189
[TBL] [Abstract][Full Text] [Related]
12. Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.
Kersseboom S; Kremers GJ; Friesema EC; Visser WE; Klootwijk W; Peeters RP; Visser TJ
Mol Endocrinol; 2013 May; 27(5):801-13. PubMed ID: 23550058
[TBL] [Abstract][Full Text] [Related]
13.
Groeneweg S; Kersseboom S; van den Berge A; Dolcetta-Capuzzo A; van Geest FS; van Heerebeek REA; Arjona FJ; Meima ME; Peeters RP; Visser WE; Visser TJ
Thyroid; 2019 Oct; 29(10):1499-1510. PubMed ID: 31436139
[No Abstract] [Full Text] [Related]
14. Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels.
Boccone L; Dessì V; Meloni A; Loudianos G
Eur J Med Genet; 2013 Apr; 56(4):207-10. PubMed ID: 23419639
[TBL] [Abstract][Full Text] [Related]
15. Altered behavioral performance and live imaging of circuit-specific neural deficiencies in a zebrafish model for psychomotor retardation.
Zada D; Tovin A; Lerer-Goldshtein T; Vatine GD; Appelbaum L
PLoS Genet; 2014 Sep; 10(9):e1004615. PubMed ID: 25255244
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression.
Wilpert NM; Krueger M; Opitz R; Sebinger D; Paisdzior S; Mages B; Schulz A; Spranger J; Wirth EK; Stachelscheid H; Mergenthaler P; Vajkoczy P; Krude H; Kühnen P; Bechmann I; Biebermann H
Thyroid; 2020 Sep; 30(9):1366-1383. PubMed ID: 32143555
[No Abstract] [Full Text] [Related]
17. Insights on the role of thyroid hormone transport in neurosensory organs and implication for the Allan-Herndon-Dudley syndrome.
García-Aldea Á; Guillén-Yunta M; Valcárcel-Hernández V; Montero-Pedrazuela A; Guadaño-Ferraz A; Bárez-López S
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38417253
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an LC-MS/MS methodology for the quantification of thyroid hormones in dko MCT8/OATP1C1 mouse brain.
De Angelis M; Maity-Kumar G; Schriever SC; Kozlova EV; Müller TD; Pfluger PT; Curras-Collazo MC; Schramm KW
J Pharm Biomed Anal; 2022 Nov; 221():115038. PubMed ID: 36152487
[TBL] [Abstract][Full Text] [Related]
19. In a zebrafish biomedical model of human Allan-Herndon-Dudley syndrome impaired MTH signaling leads to decreased neural cell diversity.
Silva N; Campinho MA
Front Endocrinol (Lausanne); 2023; 14():1157685. PubMed ID: 37214246
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone transporters and resistance.
Visser TJ
Endocr Dev; 2013; 24():1-10. PubMed ID: 23392090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
